Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography.
Marie
I
I
Lahaxe
L
L
Vera
P
P
Edet-Samson
A
A
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D019788:Fluorodeoxyglucose F18; D006801:Humans; D000069285:Infliximab; D008297:Male; D018908:Muscle Weakness / Q000000981:diagnostic imaging* / Q000188:drug therapy; D009135:Muscular Diseases / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods; D011241:Prednisone / Q000008:administration & dosage; D019275:Radiopharmaceuticals; D012507:Sarcoidosis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D019275:Radiopharmaceuticals; D014409:Tumor Necrosis Factor-alpha; D019788:Fluorodeoxyglucose F18; D000069285:Infliximab; D011241:Prednisone